Hemodynamic effect of dobutamine in patients with severe heart failure

Am J Cardiol. 1975 Aug;36(2):202-5. doi: 10.1016/0002-9149(75)90526-3.

Abstract

Dobutamine, a derivative of dopamine, was infused at a rate of 10 mug/kg per min in 15 patients with severe congestive heart failure. Cardiac output increased from an average of 3.1 to 5.6 liters/min (P less than 0.001) with no change in mean arterial pressure (93.3 to 98.2 mm Hg) and only a slight increase in heart rate (98.5 to 105.2 beats/min) (P less than 0.02). Pulmonary wedge pressure was decreased from an average of 27.4 to 21.1 mm Hg (P less than 0.001). In seven patients a dose of 5 mug/kg per min also produced a significant increase in cardiac output but the effect was less than with the 10 mug/kg per min dose. No side effects were observed during the infusion. Dobutamine therefore is a potent inotropic drug with limited chronotropic and peripheral vascular effects and deserves therapeutic trial in the short-term management of low output heart failure.

MeSH terms

  • Adult
  • Animals
  • Blood Pressure / drug effects
  • Cardiac Catheterization
  • Cardiac Output / drug effects
  • Dopamine / analogs & derivatives*
  • Dopamine / pharmacology
  • Dopamine / therapeutic use
  • Heart Conduction System / drug effects
  • Heart Failure / drug therapy*
  • Hemodynamics / drug effects*
  • Humans
  • Middle Aged
  • Myocardial Contraction / drug effects
  • Myocardium / metabolism
  • Oxygen Consumption

Substances

  • Dopamine